REFERENCES
- Alphs, L., Bossie, C. A., Sliwa, J. K., Ma, Y-W., & Turner, N. (2011). Onset of efficacy with acute long-acting injectable paliperidone palmitate treatment in markedly to severely ill patients with schizophrenia: Post hoc analysis of a randomized, double-blind clinical trial. Annals of General Psychiatry, 10, 12.
- Bossie, C. A., Sliwa, J. K., Ma, Y-W., Fu, D. J., & Alphs, L. (2011). Onset of efficacy and tolerability following the initiation dosing of long-acting paliperidone palmitate: Post-hoc analyses of a randomized, double-blind clinical trial. BMC Psychiatry, 11, 79.
- Citrome, L. (2010). Paliperidone palmitate—review of the efficacy, safety, and cost of a new second-generation depot antipsychotic medication. The International Journal of Clinical Practice, 64, 216–239.
- Cocoman, A., & Murray, J. (2008). Intramuscular injections: A review of best practice for mental health nurses. Journal of Psychiatric and Mental Health Nursing, 15, 424–434.
- Ereshefsky, L., & Mascarenas, C. A. (2003). Comparison of the effects of different routes of antipsychotic administration on pharmacokinetics and pharmacodynamics. The Journal of Clinical Psychiatry, 644(suppl 16), 18–23.
- Ereshefsky, L., Toney, G., Saklad, S. R., Anderson, C., & Seidel, D. (1993). A loading-dose strategy for converting from oral to depot haloperidol. Hospital and Community Psychiatry, 44(12), 1155–1161.
- Gilday, E., & Nasrallah, H. A. (2012). Clinical pharmacology of paliperidone palmitate a parenteral long-acting formulation for the treatment of schizophrenia. Reviews on Recent Clinical Trials, 7, 2–9.
- Janssen Pharmaceuticals, Inc. (2012). Invega Sustenna: Highlights of prescribing information. Retrieved from http://www.invegasustenna.com/important-product-information
- Koch-Weser, J., & Greenblatt, D. J. (1976). Intramuscular injection of drugs. The New England Journal of Medicine, 295, 542–546.
- Lingam, R., & Scott, J. (2002). Treatment non-adherence in affective disorders. Acta Psychiatrica Scandinavica, 105, 164–172.
- Sajatovic, M., Davies, M., & Hrouda, D. R. (2004). Enhancement of treatment adherence among patients with bipolar disorder. Psychiatric Services, 55, 264–269.
- Somani, S. M., Gupta, S. K., Frank, S., & Corder, C. N. (1990). Effect of exercise on disposition and pharmacokinetics of drugs. Drug Development Research, 20, 251–275.
- Velligan, D. I., Weiden, P. J., Sajatovic, M., Scott, J., Carpenter, D., Ross, R., Docherty, J. P., & Expert Consensus Panel on Adherence Problems in Serious and Persistent Mental Illness. (2009). The expert consensus guideline series: Adherence problems in patients with serious and persistent mental illness. The Journal of Clinical Psychiatry, 70(suppl 4), 1–46.